Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 727 | 1,435 | 0 | 0 | 0 |
| Cost of Goods | 1,515 | 1,347 | N/A | N/A | N/A |
| Gross Profit | -788 | 88 | N/A | N/A | N/A |
| Operating Expenses | 47,828 | 470,820 | 20,199 | 20,831 | 26,339 |
| Operating Income | -48,101 | -470,385 | -20,199 | -20,831 | -26,339 |
| Interest Expense | 120 | 132 | 0 | 0 | 0 |
| Other Income | 7,011 | 8,025 | 5,407 | 7,044 | 6,690 |
| Pre-tax Income | -41,210 | -462,492 | -14,792 | -13,787 | -19,649 |
| Net Income Continuous | -41,210 | -462,492 | -14,792 | -13,787 | -19,649 |
| Net Income | $-41,210 | $-462,492 | $-14,792 | $-13,787 | $-19,649 |
| EPS Basic Total Ops | -0.15 | -1.89 | -0.07 | -0.07 | -0.09 |
| EPS Basic Continuous Ops | -0.15 | -1.89 | -0.07 | -0.06 | -0.09 |
| EPS Diluted Total Ops | -0.15 | -1.89 | -0.07 | -0.07 | -0.09 |
| EPS Diluted Continuous Ops | -0.15 | -1.89 | -0.07 | -0.06 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.15 | -0.07 | -0.06 | -0.09 |
| EBITDA(a) | $-47,939 | $-470,141 | $-20,141 | $-20,776 | $-26,284 |